Vectura Group plc is a product development company specialising in inhalation drug delivery. As a Contract Research Organisation (CRO), they integrate formulation, device, and development capabilities to provide a comprehensive range of services aimed at assisting customers in bringing inhaled medicines to market. Vectura supports clients from the pre-clinical stage of development, focusing on overcoming complex inhaled formulation challenges, selecting appropriate delivery devices, and facilitating swift transitions to clinical phases. With expertise in both powder and liquid formulations and a robust portfolio of proprietary device and formulation technologies, Vectura positions itself as a leader in the inhaled medicines sector.

Services include:
- Contract Research
- Finished Dosage Forms
- Contract Manufacturing (CMO/CDMO)
- Development of Dry Powder Inhalers
- Development of Nebuliser Delivery Systems
- Smart Inhalation Therapy Solutions

Vectura Group plc continues to deliver innovative solutions and support to the pharmaceutical industry, enhancing the development of inhaled therapies. For more information, please visit vectura.com.